How much does a box of Enxidiping cost in 2024?

Enasidenib is an oral targeted drug used to treat a specific type of blood cancer, AML (acute myeloid leukemia). It belongs to the odor-acid drugs and acts on mutations in the IDH2 (isoisomerase 2) gene.

Since ensidipine has not yet been launched in the domestic market, domestic patients cannot directly purchase it domestically. To obtain this drug, patients need to purchase it through overseas channels. Abroad, the relatively economical choice is generic drugs, especially the versions produced in Laos and Bangladesh. The price range is about more than 2,000 to 4,000 yuan. At the same time, these generic drugs are highly consistent with the original drugs in terms of pharmaceutical ingredients.

AMLAbout 10% to 20% carry IDH2 gene mutations, which lead to increased enzyme activity and promote the development of AML. Ensidipine inhibits the growth and spread of tumors by inhibiting the activity of mutated IDH2 enzyme, interfering with abnormal metabolic pathways and promoting the differentiation of leukemia cells.

Ensidipine is generally used as first-line treatment for IDH2 mutation-positive relapsed or refractory AML patients. Its efficacy has been demonstrated in clinical trials, with some patients showing sustained clinical responses. However, it should be noted that ensidipine is not suitable for all AML patients and is limited to IDH2 mutation-positive cases.

When using ensidipine to treat AML, patients need to be closely monitored to ensure the efficacy and safety of the drug. Possible adverse reactions include nausea, vomiting, fatigue, abnormal liver function, etc., so regular clinical and laboratory examinations are required during treatment.

In summary, ensidipine is a drug that targets IDH2 mutations and is used to treat specific types ofAMLpatients. Its emergence has brought new treatment options to some AML patients and provided hope for improving patients' survival rate and quality of life.